MedPath

WESTERN GALILEE HOSPITAL - NAHARIYA

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

84

Active:0
Completed:41

Trial Phases

5 Phases

Phase 1:2
Phase 2:3
Phase 3:8
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (48 trials with phase data)• Click on a phase to view related trials

Not Applicable
31 (64.6%)
Phase 3
8 (16.7%)
Phase 4
4 (8.3%)
Phase 2
3 (6.3%)
Phase 1
2 (4.2%)

Evaluation of Microbial and Endocrinological Parameters in Dialysis Patients With Sepsis

Recruiting
Conditions
Sepsis
Hemodialysis
First Posted Date
2025-05-09
Last Posted Date
2025-05-14
Lead Sponsor
Western Galilee Hospital-Nahariya
Target Recruit Count
200
Registration Number
NCT06963853
Locations
🇮🇱

Galilee Medical Center, Nahariya, Israel

Comparison of Sonographic and MRI Weight Estimation in Fetuses with Suspected Macrosomia

Not Applicable
Recruiting
Conditions
Accuracy of Sonographic Vs MRI Fetal Weight Estimation
First Posted Date
2025-03-27
Last Posted Date
2025-03-27
Lead Sponsor
Western Galilee Hospital-Nahariya
Target Recruit Count
80
Registration Number
NCT06898892
Locations
🇮🇱

Galilee medical center, Nahariyya, Israel

Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo

Not Applicable
Recruiting
Conditions
Meconium-stained Amniotic Fluid
Chorioamnionitis
Interventions
Drug: zinacef tretment
Other: Placebo
First Posted Date
2025-02-27
Last Posted Date
2025-07-20
Lead Sponsor
Western Galilee Hospital-Nahariya
Target Recruit Count
182
Registration Number
NCT06849037
Locations
🇮🇱

Galilee Medical center, Nahariyya, Israel

Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)

Recruiting
Conditions
Diabetes Mellitus
Kidney Disease
First Posted Date
2025-02-12
Last Posted Date
2025-02-12
Lead Sponsor
Western Galilee Hospital-Nahariya
Target Recruit Count
70
Registration Number
NCT06821919
Locations
🇮🇱

Galilee Medical Center, Nahariya, Israel

Using Antibiotics to Prevent Infections in Hemodialysis Patients During Catheter Placement

Phase 4
Recruiting
Conditions
Infection Catheter-Related
Interventions
Drug: • Cefamezine (2 grams) and gentamicin (80 mg) administered intravenously. • Patients with penicillin allergies, a history of methicillin-resistant Staphylococcus aureus (MRSA) infection, or known MRSA
First Posted Date
2025-02-07
Last Posted Date
2025-02-07
Lead Sponsor
Western Galilee Hospital-Nahariya
Target Recruit Count
200
Registration Number
NCT06814223
Locations
🇮🇱

Galilee Medical Center, Nahariya, Israel

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.